Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 29, 2018
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
[ Thu, Nov 29th 2018
] - WOPRAI
Wed, November 28, 2018
[ Wed, Nov 28th 2018
] - WOPRAI
[ Wed, Nov 28th 2018
] - WOPRAI
[ Wed, Nov 28th 2018
] - WOPRAI
Michael Schmidt Initiated (BLUE) at Buy and Held Target at $145 on, Nov 28th, 2018
Michael Schmidt of Leerink Swann, Initiated "bluebird bio, Inc." (BLUE) at Buy and Held Target at $145 on, Nov 28th, 2018.
Michael has made no other calls on BLUE in the last 4 months.
There is 1 other peer that has a rating on BLUE. Out of the 1 peers that are also analyzing BLUE, all agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $185 on, Monday, November 5th, 2018
